India's Narcotics Control Bureau disrupted a transnational drug-trafficking network operated by foreign nationals who had illegally overstayed their visas.
The operation highlights a growing security concern regarding the intersection of illegal immigration and organized crime. By targeting individuals staying in the country without valid permits, the NCB aims to close loopholes used by global syndicates to move narcotics across borders.
Law enforcement officials conducted operations in New Delhi and Uttar Pradesh to uncover the syndicate. The resulting seizures included narcotics with an estimated value of Rs 15 crore [2].
Reports on the arrests vary. Some sources said that four Nigerians were detained [1], while other reports indicate five foreign nationals, including a woman, were arrested [2, 3]. The NCB said the network relied on the anonymity provided by overstaying foreign nationals to coordinate the flow of illicit substances.
In response to these findings, the agency announced a nationwide initiative called "Trinetra." This drive is scheduled for the month following the bust and will last for a fortnight [1]. The 14-day operation is designed specifically to locate and identify foreign nationals who are illegally residing in India [1].
The NCB said the effort to curb the flow of narcotics is inextricably linked to addressing the problem of illegal overstays. By synchronizing drug enforcement with immigration checks, the agency intends to dismantle the support structures that transnational gangs use to operate within Indian borders.
“NCB disrupted a transnational drug-trafficking network operated by foreign nationals who had illegally overstayed their visas.”
The launch of the Trinetra drive suggests a strategic shift by Indian authorities to treat visa violations not merely as administrative errors, but as potential security vulnerabilities. By linking immigration status to narcotics trafficking, the NCB is signaling that the monitoring of foreign nationals will become a primary tool in disrupting the logistics of global drug syndicates.
